Name | 3-[4-hydroxy-3-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid |
---|
Description | CD3254 a potent and selective retinoid-X-receptor (RXR) agonist[1]. |
---|---|
Related Catalog | |
Target |
RXR |
In Vitro | CD3254 induces similar phenotypes of malformations after 5 days exposure at low concentration (20 μg/L) to those after the 1st d exposure at high concentrations (50 and 100 μg/L)[1]. Cell Viability Assay[1] Cell Line: zebrafish (Danio rerio) embryos Concentration: 10, 20, 50, 100 μg/L Incubation Time: Result: The percent of survival decreased by 19.1 % in 100 μg/L CD3254-treated group after the 1st day exposure. The embryos did not hatch in groups exposed to 100 μg/L CD3254 for 5 days or to 1 mg/L CD3254 for the 1st day. |
References |
Molecular Formula | C24H28O3 |
---|---|
Molecular Weight | 364.47700 |
Exact Mass | 364.20400 |
PSA | 57.53000 |
LogP | 5.81440 |